- Home
- CDNA vs MTAL Comparison
CDNA vs MTAL Comparison
Compare CDNA & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- MTAL
- Stock Information
- Founded
- CDNA 1998
- MTAL 2021
- Country
- CDNA United States
- MTAL Jersey
- Employees
- CDNA N/A
- MTAL N/A
- Industry
- CDNA Medical Specialities
- MTAL Blank Checks
- Sector
- CDNA Health Care
- MTAL Finance
- Exchange
- CDNA Nasdaq
- MTAL Nasdaq
- Market Cap
- CDNA 1.0B
- MTAL 997.3M
- IPO Year
- CDNA 2014
- MTAL 2021
- Fundamental
- Price
- CDNA $12.92
- MTAL $12.11
- Analyst Decision
- CDNA Buy
- MTAL Hold
- Analyst Count
- CDNA 6
- MTAL 4
- Target Price
- CDNA $29.33
- MTAL $12.08
- AVG Volume (30 Days)
- CDNA 2.1M
- MTAL 639.0K
- Earning Date
- CDNA 07-30-2025
- MTAL 07-23-2025
- Dividend Yield
- CDNA N/A
- MTAL N/A
- EPS Growth
- CDNA N/A
- MTAL N/A
- EPS
- CDNA 1.07
- MTAL N/A
- Revenue
- CDNA $346,421,000.00
- MTAL $340,736,000.00
- Revenue This Year
- CDNA $13.31
- MTAL $18.41
- Revenue Next Year
- CDNA $15.46
- MTAL $23.55
- P/E Ratio
- CDNA $12.11
- MTAL N/A
- Revenue Growth
- CDNA 25.92
- MTAL 114.30
- 52 Week Low
- CDNA $10.96
- MTAL $7.69
- 52 Week High
- CDNA $34.84
- MTAL $14.31
- Technical
- Relative Strength Index (RSI)
- CDNA 28.64
- MTAL 58.45
- Support Level
- CDNA $11.62
- MTAL $11.96
- Resistance Level
- CDNA $13.15
- MTAL $12.09
- Average True Range (ATR)
- CDNA 1.36
- MTAL 0.08
- MACD
- CDNA -0.91
- MTAL -0.05
- Stochastic Oscillator
- CDNA 18.04
- MTAL 40.91
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.